These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36688192)

  • 1. The Role of Immunosuppression in the Development of COVID-19 in Systemic Lupus Erythematosus Patients: A Brief Report.
    Damirchi M; Aghaie M; Sedighi S; Tavassoli S; Roshandel G; Hassani M; Abdolahi N
    Iran J Med Sci; 2023 Jan; 48(1):91-97. PubMed ID: 36688192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
    Espinosa G; Prieto-González S; Llevadot M; Marco-Hernández J; Martínez-Artuña A; Pérez-Isidro A; Rifé E; Cervera R
    Clin Rheumatol; 2021 May; 40(5):2057-2063. PubMed ID: 33677725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China.
    Liu PC; Zhang M; Li JB; Peng YL; Yu SJ; Wu R
    Lupus; 2024 Apr; 33(4):357-364. PubMed ID: 38314781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort.
    Walbi IA; Albarqi HA; Alghanim NS; Albadi MA; Al Maimouni HM; Alkahtani SA; Alshabi AM; Alali AS; Alqahtani F; Al-Najjar AH; Hazzazi MA; Alanazi DS; Sabei AA; Alsaweed OS; Alajra RK; Alqhtani H
    J Int Med Res; 2022 Apr; 50(4):3000605221090363. PubMed ID: 35387504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on SLE.
    Zhao X; Wu H; Li S; Gao C; Wang J; Ge L; Song Z; Ni B; You Y
    Mod Rheumatol; 2024 Feb; 34(2):247-264. PubMed ID: 36961736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in patients with systemic lupus erythematosus: A systematic review.
    Fu XL; Qian Y; Jin XH; Yu HR; Du L; Wu H; Chen HL; Shi YQ
    Lupus; 2022 May; 31(6):684-696. PubMed ID: 35382637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of SLE patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period.
    Hassan KS; Al Lawati B; Rizvi GA
    Lupus; 2023 Sep; 32(10):1173-1178. PubMed ID: 37471705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.
    Jallouli M; Saadoun D; Eymard B; Leroux G; Haroche J; Le Thi Huong D; De Gennes C; Chapelon C; Benveniste O; Wechsler B; Cacoub P; Amoura Z; Piette JC; Costedoat-Chalumeau N
    J Neurol; 2012 Jul; 259(7):1290-7. PubMed ID: 22160434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Systemic Lupus Erythematous in COVID-19 Era.
    Lupu A; Miron IC; Gavrilovici C; Raileanu AA; Starcea IM; Ioniuc I; Azoicai A; Mocanu A; Butnariu LI; Dragan F; Lupu VV
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus, vaccinations and COVID-19: What we know now.
    Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
    Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort.
    Patil A; Shobha V; Shenoy P; S C; Kumar S; Daware M; Haridas V; Janardana R; Pinto B; Kodishala C; Ramaswamy S; S N; Jain V; Singh YP; Singhai S; C S; Jois R; Rao VK; Dharmapalaiah C; Kn S; Balebail D
    Lupus; 2023 Apr; 32(4):560-564. PubMed ID: 36731873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine.
    Tejada Cifuentes F; Lloret Callejo Á; Tirado Peláez MJ; Rubio Pulido O; Ruiz-Morote Aragón M; Fernández Urrusuno R; Muñoz Carreras MI; Méndez Esteban MI; Maestre Sánchez V; García Bonilla A; Paredero Dominguez JM; Arroyo Pineda V; Marco Tejón E; Romero Candel G; Fernández Marchante AI; Marco Del Rio J; Ortiz Martín T; López Sánchez P
    Med Clin (Barc); 2021 Feb; 156(4):166-171. PubMed ID: 33308853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
    Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20-Year-old female with fever, cough, and dyspnea: Acute lupus pneumonitis during the pandemic of coronavirus disease 2019 (COVID-19).
    Yarkan Tuğsal H; İzdeş S; Küçükşahin O
    Lupus; 2021 Oct; 30(11):1856-1862. PubMed ID: 34459300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus manifestation following COVID-19: a case report.
    Zamani B; Moeini Taba SM; Shayestehpour M
    J Med Case Rep; 2021 Jan; 15(1):29. PubMed ID: 33494816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
    Su L; Qi Z; Guan S; Wei L; Zhao Y
    Front Immunol; 2022; 13():978910. PubMed ID: 36238309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
    Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
    Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.